Cencora EBITDA 2010-2025 | COR
Cencora annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cencora EBITDA for the quarter ending March 31, 2025 was $1.300B, a 56.08% increase year-over-year.
- Cencora EBITDA for the twelve months ending March 31, 2025 was $3.648B, a 0.15% increase year-over-year.
- Cencora 2024 annual EBITDA was $3.294B, a 0.83% decline from 2023.
- Cencora 2023 annual EBITDA was $3.322B, a 7.98% increase from 2022.
- Cencora 2022 annual EBITDA was $3.076B, a 6.05% increase from 2021.
| Cencora Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $3,294 |
| 2023 | $3,322 |
| 2022 | $3,076 |
| 2021 | $2,901 |
| 2020 | $-4,366 |
| 2019 | $1,609 |
| 2018 | $2,013 |
| 2017 | $1,493 |
| 2016 | $1,918 |
| 2015 | $678 |
| 2014 | $979 |
| 2013 | $1,069 |
| 2012 | $1,444 |
| 2011 | $1,296 |
| 2010 | $1,181 |
| 2009 | $978 |
| Cencora Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,300 |
| 2024-12-31 | $988 |
| 2024-09-30 | $406 |
| 2024-06-30 | $953 |
| 2024-03-31 | $833 |
| 2023-12-31 | $1,101 |
| 2023-09-30 | $761 |
| 2023-06-30 | $947 |
| 2023-03-31 | $805 |
| 2022-12-31 | $809 |
| 2022-09-30 | $629 |
| 2022-06-30 | $663 |
| 2022-03-31 | $960 |
| 2021-12-31 | $825 |
| 2021-09-30 | $768 |
| 2021-06-30 | $752 |
| 2021-03-31 | $729 |
| 2020-12-31 | $652 |
| 2020-09-30 | $-5,652 |
| 2020-06-30 | $504 |
| 2020-03-31 | $410 |
| 2019-12-31 | $373 |
| 2019-09-30 | $293 |
| 2019-06-30 | $519 |
| 2019-03-31 | $184 |
| 2018-12-31 | $613 |
| 2018-09-30 | $341 |
| 2018-06-30 | $535 |
| 2018-03-31 | $607 |
| 2017-12-31 | $531 |
| 2017-09-30 | $-23 |
| 2017-06-30 | $278 |
| 2017-03-31 | $731 |
| 2016-12-31 | $506 |
| 2016-09-30 | $328 |
| 2016-06-30 | $629 |
| 2016-03-31 | $1,050 |
| 2015-12-31 | $-89 |
| 2015-09-30 | $620 |
| 2015-06-30 | $403 |
| 2015-03-31 | $-308 |
| 2014-12-31 | $-37 |
| 2014-09-30 | $266 |
| 2014-06-30 | $160 |
| 2014-03-31 | $347 |
| 2013-12-31 | $205 |
| 2013-09-30 | $158 |
| 2013-06-30 | $178 |
| 2013-03-31 | $392 |
| 2012-12-31 | $341 |
| 2012-09-30 | $361 |
| 2012-06-30 | $361 |
| 2012-03-31 | $409 |
| 2011-12-31 | $313 |
| 2011-09-30 | $245 |
| 2011-06-30 | $349 |
| 2011-03-31 | $396 |
| 2010-12-31 | $307 |
| 2010-09-30 | $250 |
| 2010-06-30 | $308 |
| 2010-03-31 | $336 |
| 2009-12-31 | $288 |
| 2009-09-30 | $250 |
| 2009-06-30 | $237 |
| 2009-03-31 | $271 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $54.103B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.708B | 26.39 |
| Elevance Health (ELV) | United States | $84.816B | 10.94 |
| CVS Health (CVS) | United States | $76.534B | 9.51 |
| DiDi Global (DIDIY) | China | $21.367B | 32.43 |
| Natera (NTRA) | United States | $20.793B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.720B | 13.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.739B | 0.00 |
| Revvity (RVTY) | United States | $11.399B | 19.62 |
| CochLear (CHEOY) | Australia | $11.361B | 0.00 |
| ICON (ICLR) | Ireland | $11.346B | 10.55 |
| Doximity (DOCS) | United States | $11.282B | 58.67 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $9.063B | 13.17 |
| Medpace Holdings (MEDP) | United States | $8.914B | 23.68 |
| HealthEquity (HQY) | United States | $8.389B | 41.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.349B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.074B | 13.86 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| BrightSpring Health Services (BTSG) | United States | $4.049B | 37.48 |
| Sotera Health (SHC) | United States | $3.758B | 21.35 |
| Surgery Partners (SGRY) | United States | $2.939B | 38.22 |
| Alignment Healthcare (ALHC) | United States | $2.780B | 0.00 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.194B | 2.33 |
| Premier (PINC) | United States | $2.087B | 14.29 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.858B | 40.91 |
| GeneDx Holdings (WGS) | United States | $1.739B | 66.96 |
| PACS (PACS) | United States | $1.669B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.650B | 30.71 |
| Teladoc Health (TDOC) | United States | $1.337B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.239B | 9.42 |
| Agilon Health (AGL) | United States | $1.118B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.011B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.898B | 14.03 |
| AMN Healthcare Services Inc (AMN) | United States | $0.830B | 7.77 |
| Embecta (EMBC) | United States | $0.731B | 4.92 |
| Nutex Health (NUTX) | United States | $0.696B | 10.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.691B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| Enhabit (EHAB) | United States | $0.530B | 43.62 |
| Auna S.A (AUNA) | Luxembourg | $0.510B | 13.51 |
| Sonida Senior Living (SNDA) | United States | $0.510B | 0.00 |
| LifeMD (LFMD) | United States | $0.387B | 0.00 |
| SBC Medicals (SBC) | United States | $0.363B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.362B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Sera Prognostics (SERA) | United States | $0.089B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| KindlyMD (KDLY) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |